Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [31] Tissue Based Biomarkers for Metastatic Clear Cell Renal Carcinoma: A Systematic Review
    Schmidt, Andrew L.
    Bain, Paul A.
    McGregor, Bradley A.
    KIDNEY CANCER, 2020, 4 (04) : 197 - 210
  • [32] Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Harris, Wayne B.
    Kucuk, Omer
    Carthon, Bradley C.
    Gillespie, Theresa W.
    Master, Viraj A.
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2017, 30 : 229A - 229A
  • [33] Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Harris, Wayne B.
    Kucuk, Omer
    Carthon, Bradley C.
    Gillespie, Theresa W.
    Master, Viraj A.
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2017, 97 : 229A - 229A
  • [34] Update on targeted therapies for clear cell renal cell carcinoma
    Singer, Eric A.
    Gupta, Gopal N.
    Srinivasan, Ramaprasad
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (03) : 283 - 289
  • [35] Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Osterman, Chelsea K.
    Deal, Allison M.
    Milowsky, Matthew, I
    Bjurlin, Marc A.
    Rose, Tracy L.
    KIDNEY CANCER, 2020, 4 (03) : 131 - 137
  • [36] Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
    Fujiwara, Motohiro
    Shimada, Wataru
    Yokoyama, Minato
    Koyanagi, Anri
    Shintaku, Hiroshi
    Fukuda, Shohei
    Waseda, Yuma
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    IJU CASE REPORTS, 2024, 7 (04) : 293 - 296
  • [37] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
  • [38] Intraventricular metastatic clear cell renal carcinoma
    Sava, I.
    Sava, Anca
    Sapte, Elena
    Mihailov, Claudia
    Dumitrescu, Gabriela
    Poeata, I.
    Sava, Florina
    Haba, Danisia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (02): : 447 - 450
  • [39] Metastatic periampullary clear cell renal carcinoma
    Jideh, Bilel
    Chen, Hank
    Weltman, Martin
    Chan, Calvin H. Y.
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : 1040 - 1041
  • [40] Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
    Del Vecchio, Sharon J.
    Ellis, Robert J.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (04): : 1 - 5
12345